Altered Regulation of Type II 11β-hydroxysteroid Dehydrogenase in the Kidney of Rats with Experimental Hypertension
- PMID: 24459506
- PMCID: PMC3894520
- DOI: 10.5049/EBP.2007.5.2.89
Altered Regulation of Type II 11β-hydroxysteroid Dehydrogenase in the Kidney of Rats with Experimental Hypertension
Abstract
The present study was aimed at investigating the role of type II 11β-hydroxysteroid dehydrogenase (IIβ-HSD II) in the development of hypertension. Two-kidney, one-clip (2K1C), deoxycorticosterone acetate (DOCA)/salt, or N (G)-nitro-L-arginine methyl ester (L-NAME) hypertension was induced in male Sprague-Dawley rats. Four weeks later, the expression of 11β-HSD II mRNA was determined in the kidney by Northern blot analysis. The plasma level of aldosterone was measured by radioimmunoassay. In 2K1C hypertension, the expression of 11β-HSD II was decreased in the clipped kidney and increased in the non-clipped kidney. The expression was increased in the remnant kidney of DOCA/salt hypertension, while decreased in the kidneys of L-NAME hypertension. The plasma level of aldosterone was increased, decreased, and remained unchanged in 2K1C, DOCA/salt, and L-NAME hypertension, respectively. The down-regulation of 11β-HSD II may contribute to the sodium retention, thereby increasing the blood pressure in 2K1C and L-NAME hypertension. On the contrary, the up-regulation in DOCA/salt hypertension may play a compensatory role to dissipate the sodium retention.
Keywords: Hypertension; Kidney; Type II 11β-hydroxysteroid dehydrogenase.
Figures




Similar articles
-
Regulation of the genes for 11beta-hydroxysteroid dehydrogenase type 1 and type 2 in the kidney of the Dahl rat.J Hypertens. 1999 Aug;17(8):1089-93. doi: 10.1097/00004872-199917080-00007. J Hypertens. 1999. PMID: 10466463
-
Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.Hypertension. 1998 Feb;31(2):649-56. doi: 10.1161/01.hyp.31.2.649. Hypertension. 1998. PMID: 9461236
-
Altered expression of vascular natriuretic peptide receptors in experimental hypertensive rats.Clin Exp Pharmacol Physiol. 2002 Apr;29(4):299-303. doi: 10.1046/j.1440-1681.2002.03647.x. Clin Exp Pharmacol Physiol. 2002. PMID: 11985539
-
Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension.Semin Vasc Med. 2004 May;4(2):121-8. doi: 10.1055/s-2004-835369. Semin Vasc Med. 2004. PMID: 15478032 Review.
-
11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?Front Neuroendocrinol. 1997 Jan;18(1):49-99. doi: 10.1006/frne.1996.0143. Front Neuroendocrinol. 1997. PMID: 9000459 Review.
References
-
- Eaton DC, Becchetti A, Ma H, Ling BN. Renal sodium channels: regulation and single channel properties. Kidney Int. 1995;48:941–949. - PubMed
-
- Renard S, Voilley N, Bassilana F, Lazdunski M, Barbry P. Localization and regulation by steroids of the alpha, beta and gamma subunits of the amiloride-sensitive Na+ channel in colon, lung and kidney. Pflugers Arch. 1995;430:299–307. - PubMed
-
- Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988;242:583–585. - PubMed
-
- Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, DeKloet ER, Monder C. Localization of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986–989. - PubMed
-
- Rundle SE, Funder JW, Lakshmi V, Monder C. The intrarenal localization of mineralocorticoid receptors and 11β-dehydrogenase: immunocytochemical studies. Endocrinology. 1989;125:1700–1704. - PubMed
LinkOut - more resources
Full Text Sources